Growth hormone and the microvascular complications of diabetes.
The basis for the hypothesis that growth hormone is a permissive factor in the pathogenesis of diabetic microvascular complications is a weak one. The best way forward in this research will be to devise a pharmacological method of suppressing growth hormone secretion in diabetic subjects.